Machine Learning

Fintech innovator Pipe raises $16M in a new round, signaling strong investor confidence in its model of providing fast, embedded capital to small businesses.

As CMS halts new provider enrollments to fight waste, one company's new model for incontinence supplies could offer a blueprint for industry-wide reform.

A new non-invasive therapy using ultrasound to activate a cancer-targeting drug enters a crucial Phase 2b trial, offering new hope for glioblastoma patients.

SQWAD joins Tagboard's App Marketplace, offering teams a seamless way to deploy sponsored games and unlock new, measurable sponsorship revenue streams.

In a strategic move to capture the North American market, Devicie appoints Alex Hesterberg, a leader known for scaling high-growth tech firms, as its new CEO.

New research reveals 75% of manufacturing failures happen at the factory, costing billions. The industry has been solving the wrong problem for years.

A new maternal blood test claims over 97% accuracy in predicting autism risk, offering hope for early intervention while igniting a fierce ethical debate.

The global tech firm has launched autonomous AI agents to manage menus and sales, promising a new era of efficiency while raising questions about the future of jobs.

Software pioneer Horizon Quantum acquires a powerful 256-qubit IonQ computer, a key step in creating a universal platform for quantum developers.

With its European trial launch, Kainova's DT-7012 aims to disarm cancer's bodyguards, offering new hope for patients with advanced solid tumors.

With the hire of a top scientist, a minority-owned IT firm signals its ambition to tackle complex federal health challenges and compete with industry giants.

Karl Blackburn, former head of Quebec’s top employers’ council, takes the helm at the Montreal Heart Institute Foundation, signaling a new era.

Eli Lilly's new once-daily oral GLP-1, Foundayo, is now on telehealth platform Ro, offering a convenient, needle-free alternative to injectable drugs.

OncoC4 begins a landmark trial for ONC-841, a drug targeting immune cells in the brain, offering a new front in the fight against Alzheimer's disease.

Ease.io's annual awards highlight the leaders and technologies redefining factory excellence, from individual trailblazers to data-driven plant transformations.

Top tech leaders gather in Jakarta for the BFSI IT Summit to navigate AI, cybersecurity, and the challenges of Indonesia's digital banking revolution.

Pittsburgh-based IT firm CEI bets its future on AI, appointing a top industry veteran to transform the 30-year-old company in a competitive market.

A Swiss biotech's novel antibiotic has entered human trials with new funding, offering a fresh hope against the world's most dangerous superbugs.

Following a $47.5M funding round, CertifID is bolstering its leadership to fight a new wave of sophisticated, AI-driven wire fraud in real estate.

Aitech's new SOSA-aligned SBCs feature Intel's 14th Gen Core Ultra, bringing unprecedented AI processing directly to the tactical frontline.